The new classification model is based on Qlucore's knowledge and workflows for developing gene expression-based machine learning (ML) models (AI-based) and has been trained on hundreds of carefully selected tissue samples from lung cancer.
Precision diagnostics for cancer have advanced rapidly in recent years, driven by next-generation sequencing (NGS). Up until now, the focus has been on mutations and variants in the genetic code, which have been used for patient stratification and decisions on cancer treatment. However, there has been increasing interest in techniques based on measurements of gene activity levels (gene expression) as it provides additional opportunities to describe the type of treatment a patient should receive.
Qlucore Insights is intended for research and enables early testing and evaluation. Qlucore Insights is provided to hospitals, clinics, and laboratories via Qlucore's European sales force.
Qlucore Diagnostics fills an important gap in the workflow for clinical precision diagnostics. With disease-specific ML models that enable classification and a feature supporting clinical decision-making, including user-friendly 3D visualisations, it becomes possible to predict patients' responses to treatment. Qlucore Diagnostics is the future solution for personalised cancer treatment, and the goal is to obtain CE marking.About Qlucore
Qlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore's mission is to make it easier to analyse the huge amounts of complex data generated by innovations in the fields of genomics and proteomics by providing powerful visualisation-based bioinformatics data analysis tools for research and precision diagnostics. Qlucore Omics Explorer software is a DIY bioinformatics software for research in the life sciences, plant and biotech industries, as well as academia. Qlucore Diagnostics and Qlucore Insights are software platforms with built in AI-based ML for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 in Lund, Sweden and has customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Visit: www.qlucore.com